RPT-EXCLUSIVE-Lilly hit by staff accusations, FDA scrutiny at COVID drug factories
RPT-EXCLUSIVE-Lilly hit by staff accusations, FDA scrutiny at COVID drug factories Reuters 3 hrs ago (Repeats to additional subscribers with no changes to the text) By Dan Levine and Marisa Taylor May 5 (Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatment, according to an internal Lilly complaint and a source familiar with the matter. The unsigned report, filed April 8 in Lilly’s confidential emp...